CAPITOL HILL CONSULTING GROUP for NOVARTIS CORPORATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
General FDA funding issues; FY2011 Labor-HHS-Education Appropriations; FY2011 Supplemental Appropriations; Pandemic vaccine issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| DAVID JORY | — |
Government Issues GOV
General patent issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| DAVID JORY | — |
Taxation/Internal Revenue Code TAX
H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID JORY | — |
Medicare/Medicaid MMM
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| DAVID JORY | — |
Health Issues HCR
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); follow-on biologics; Preserve Access to Affordable Generics Act (S. 369)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| DAVID JORY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.